Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002211908 | SCV002353731 | likely benign | Familial meningioma | 2023-03-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004681430 | SCV005171200 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-04-02 | criteria provided, single submitter | clinical testing | The c.1080C>T variant (also known as p.G360G), located in coding exon 10 of the SMARCE1 gene, results from a C to T substitution at nucleotide position 1080. This nucleotide substitution does not change the glycine residue at codon 360. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. Based on the available evidence, the clinical significance of this alteration remains unclear. |